Role of Dhataki Pushpa Churna in Heavy Menstrual Bleeding

Phase 4

Not yet recruiting

• Conditions: Excessive and frequent menstruation with irregular cycle. Ayurveda Condition: ASRUGDARAH/RAKTAPRADARAH,

• Registration Number: CTRI/2023/05/052474
• Lead Sponsor: Ch. Brahm Prakash Ayurved Charak Sansthan

Brief Summary

Any abnormality in rutuchakra (menstrual rhythem) which leads to excessive and irregular uterine bleeding  is known as Asrugdara.

Heavy menstrual bleeding is the term for menstrual periods with abnormally heavy ( >80 ml) or prolonged bleeding (>7 days) that interferes with the women’s physical, emotional, social and maternal quality of life.



The present study is aimed to find out the efficacy of dhataki pushpa churna along with tandulodaka in asrugdara.



Study type is Interventional and Study design is single arm clinical trial with sample size of 55 patients.



Dhataki Pushpa Churna will be given in the dose of 5gm with Tandulodaka , Twice Daily, Before meal (Apan Kala) for two consecutive cycles.



This study is expected to be beneficial in clinical management of Asrugdara ( Heavy Menstrual Bleeding)

Detailed Description

Not available

Study Timeline

• Study Start: 2023-05-25
• Last Update Posted: 2023-09-05

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Female
• Target Recruitment: 55

Inclusion Criteria

Duration of menstrual flow >7days Irregular and excessive Menstrual bleeding Reduction in the inter menstrual cycle period Patient with heavy menstrual bleeding since two consecutive cycles atleast.

Exclusion Criteria

• Patients with any co-morbities.
• Coagulative Disorders Patient with any other organic lesion i.e. uterine fibroid, ovarian cyst, carcinoma etc.
• IUCD Pregnancy Hb% < 8mg/dl.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Findings of the study will be beneficial in the clinical management of Asrugdara (Heavy	Two Consecutive Cycles
menstrual bleeding) by establishing the efficacy of dhataki pushpa churna .	Two Consecutive Cycles

Secondary Outcome Measures

Name	Time	Method
This study will provide cost effective, safe drug with lesser side effects

Trial Locations

Locations (1)

Ch. Brahm Prakash Ayurved Charak Sansthan; 🇮🇳 West, DELHI, India

Ch. Brahm Prakash Ayurved Charak Sansthan

🇮🇳West, DELHI, India

Dr Renu Yadav

Principal investigator

8510985411

renuyadav2736@gmail.com